Home
Blog
Resources
Why News Quantified Works
The Ultimate Earnings Guide
STOCK MARKET 101
About Us
Contact
Services
Institutions
Market Impact Report
Sign up
Log in
Home
Blog
Resources
Why News Quantified Works
The Ultimate Earnings Guide
STOCK MARKET 101
About Us
Contact
Services
Institutions
Market Impact Report
Log in
Sign up
×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks
Home
ACIU
News
ACIU –
ac immune sa
(US:NASDAQ)
DELAYED
<
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
——
ACIU
SPY
QQQ
SPX
News
Earning News
Analyst Actions
SEC Filings
Date
Time
Symbol
Headline
Impact
9/9
06:32 am
aciu
Slovakian biotech firm signals tentative Alzheimer's drug hope [Reuters (UK)]
Medium
REPORT
9/9
06:20 am
aciu
Slovakian biotech firm signals tentative Alzheimer's drug hope [Reuters]
Medium
REPORT
9/9
06:00 am
aciu
UPDATE 1-Slovakian biotech firm signals tentative Alzheimer's drug hope [Reuters]
Medium
REPORT
9/4
07:00 am
aciu
AC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinson’s Disease Diagnostic Imaging Agent
Low
REPORT
8/28
04:00 am
aciu
AC Immune SA (NASDAQ: ACIU) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating.
Medium
REPORT
8/14
07:00 am
aciu
AC Immune Reports Q2 2019 Financial Results, Business and Clinical Update
Low
REPORT
8/12
07:00 am
aciu
AC Immune Announces Research Collaboration with University of Pennsylvania Focusing on Pathogenic Protein TDP-43 in Neurodegenerative Diseases
Medium
REPORT
8/2
03:08 am
aciu
AC Immune SA (NASDAQ: ACIU) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating.
Low
REPORT
8/1
07:00 am
aciu
AC Immune Initiates Ph1b/2a Study of Anti-Phospho-Tau Vaccine in Alzheimer’s Disease
Low
REPORT
7/26
01:28 pm
aciu
Early Results On Alzheimer's Vaccine Trial In People With Down Syndrome Promising, Researchers Say [Forbes]
Low
REPORT
7/17
07:00 am
aciu
AC Immune Initiates Phase 1 Study of ACI-3024 Small Molecule Tau Morphomer™, an Investigational Treatment for Alzheimer’s Disease
Medium
REPORT
7/14
09:29 pm
aciu
AC Immune SA (NASDAQ: ACIU) was given a new $8.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.
Low
REPORT
7/11
08:00 am
aciu
AC Immune Hosts KOL Event and Reports Initial Interim Clinical Data for ACI-24 Vaccine to Treat Alzheimer’s Disease-like Symptoms in Subjects with Down Syndrome
Medium
REPORT
6/28
08:36 am
aciu
AC Immune Announces Election of New Chairman of the Board at Annual General Meeting
Low
REPORT
6/27
07:00 am
aciu
AC Immune to Host Key Opinion Leader Meeting on Treating Alzheimer’s in Down Syndrome
Low
REPORT
6/20
07:00 am
aciu
AC Immune Reports Initiation of a Phase 2 Substudy to Increase Understanding of Disease Progression in Familial Alzheimer’s Disease
Low
REPORT
Live Event:
Click Here To Register For The Live Online Workshop
Latest Posts
Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day